Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-011662

Chief Executive Officer sold 20,000 shares at an average $46.92 ($938,459)

  • Chief Executive Officer acquired 3,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-15 Sale : show line 1 in the form −2,500 $45.58 $113,950 260,378 I
2018-02-15 Sale : show line 2 in the form −2,433 $46.71 $113,645 257,945 I
2018-02-15 Sale : show line 3 in the form −4,767 $47.56 $226,719 253,178 I
2018-02-15 Sale : show line 4 in the form −300 $48.25 $14,475 252,878 I
2018-02-16 Sale : show line 5 in the form −3,000 $45.44 $136,320 249,878 I
2018-02-16 Sale : show line 6 in the form −1,600 $46.55 $74,480 248,278 I
2018-02-16 Sale : show line 7 in the form −5,100 $47.91 $244,341 243,178 I
2018-02-16 Sale : show line 8 in the form −300 $48.43 $14,529 242,878 I
2018-02-15 Exercise or conversion : show line 9 in the form +3,938 812,613 D
Open-market sales · 20,000 sh · avg $46.92 · $938,459

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-02-15 Exercise or conversion : show line 10 in the form Restricted Stock Units −3,938 0 D
Loading xslF345X03/doc4.xml…